EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation

Oussama M Wazni, K R Julian Chun, Devi G Nair, Ante Anic, Mattias Duytschaever, Jonathan Chrispin, Anish Amin, Olujimi A Ajijola, Douglas N Gibson, Moussa Mansour, Jonathan P Piccini, Andrea Natale und 24 weitere

New England Journal of Medicine · 25.06.2026 · 394 (24) · 2407-2418

DOI: 10.1056/nejmoa2600929 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 25.06.2026. Verfasst von Oussama M Wazni und 35 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic, Cleveland. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Arrhythmia AgentsAtrial FibrillationCatheter AblationAgedFemaleHumansMaleMiddle AgedCombined Modality TherapyKaplan-Meier EstimateRecurrenceAmiodaroneRetreatmentTreatment Outcome

Substanzen

Anti-Arrhythmia AgentsAmiodarone

Autor:innen und Institutionen

  • Cleveland Clinic, Cleveland.
  • Cardioangiologisches Centrum Bethanien, Frankfurt, Germany.
  • St. Bernards Medical Center and Arrhythmia Research Group, Jonesboro, AR.
  • Split University Clinical Hospital, Split, Croatia.
  • St. Jan Hospital, Bruges, Belgium.
  • Johns Hopkins University School of Medicine, Baltimore.

ORCID-Profile: Stanislav Weiner, Jason G Andrade

Förderung

  • Boston Scientific Corporation

Zitieren

APA

Wazni, O. M., Chun, K. R. J., Nair, D. G., Anic, A., Duytschaever, M., Chrispin, J., Amin, A., Ajijola, O. A., Gibson, D. N., Mansour, M., Piccini, J. P., Natale, A., Badin, A., Osca, J., Dukes, J., Bhalla, K., Hussein, A., Senn, T., Weiner, S., …, & AVANT GUARD Study Investigators (2026). Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation. New England Journal of Medicine, 394(24), 2407-2418. https://doi.org/10.1056/nejmoa2600929

Vancouver

Wazni OM, Chun KRJ, Nair DG, Anic A, Duytschaever M, Chrispin J, et al. Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation. New England Journal of Medicine. 2026;394(24):2407-2418. doi:10.1056/nejmoa2600929

BibTeX
@article{Wazni2026,
  author = {Wazni, Oussama M and Chun, K R Julian and Nair, Devi G and Anic, Ante and Duytschaever, Mattias and Chrispin, Jonathan and Amin, Anish and Ajijola, Olujimi A and Gibson, Douglas N and Mansour, Moussa and Piccini, Jonathan P and Natale, Andrea and Badin, Auroa and Osca, Joaquin and Dukes, Jonathan and Bhalla, Karan and Hussein, Ayman and Senn, Todd and Weiner, Stanislav and Sood, Nitesh and Dello Russo, Antonio and Sadhu, Ashish and Meyers, Jason and Trulock, Kevin and Tam, Mark T K and DeLurgio, David B and Champagne, Jean and Iacopino, Saverio and Kwan, Brian and Albrecht, Elizabeth M and McCammon, Sheryl and Garlitski, Ann C and Sutton, Brad S and Stein, Kenneth M and Andrade, Jason G and AVANT GUARD Study Investigators, AVANT GUARD Study Investigators},
  title = {Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {24},
  pages = {2407--2418},
  doi = {10.1056/nejmoa2600929}
}
Kostenlos starten →